‌

US Patent 11400132 Ophthalmic compositions comprising ciclosporin

Patent 11400132 was granted and assigned to Novaliq on August, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Ralf Grillenberger0

Johan Engblom0

Frank Löscher0

Date of Patent

August 2, 2022

0

Patent Application Number

170694170

Date Filed

October 13, 2020

0

Patent Citations

US Patent 10064944 Liquid pharmaceutical composition for the treatment of a posterior eye disease

US Patent 10130707 Topical pharmaceutical composition based on semifluorinated alkanes

US Patent 10273298 Stabilized antibody compositions

US Patent 10369117 Compositions comprising mixtures of semifluorinated alkanes

0

US Patent 10449164 Methods of treating ocular disorders using semifluorinated alkanes

0

US Patent 10507132 Topical administration method

US Patent 10525062 Pharmaceutical composition for treatment of increased intraocular pressure

US Patent 10555953 Pharmaceutical composition for treatment of increased intraocular pressure

...

Patent Citations Received

US Patent 12128010 Semifluorinated compounds and their compositions

0

Patent Primary Examiner

Christina Bradley

0

The present invention relates to compositions in the form of a clear solution comprising ciclosporin with low residual water content and 1-perfluorobutyl-pentane. The compositions may be used for topical administration to the eye.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11400132 Ophthalmic compositions comprising ciclosporin

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.